Please rotate your device

GET PROPEL

Stay Informed

You are leaving the HCP website

You are being directed to a third-party website. Please note that this third-party website is not controlled by PROPELOpens.com.

Thank you for visiting our site.

Continue

YOUR ACTION PLAN FOR THE
MAXILLARY SINUS

Only PROPEL Contour combines mechanical spacing and localized drug delivery to the maxillary sinus, thereby maintaining sinus patency1

Watch Dr. McKinney discuss the case of a 59-year-old woman with CRS and nasal polyposis refractory to medical management and prior MAXILLARY sinus surgery

HISTORY AND PRESENTING SYMPTOMS*

  • Developed bacterial infection postsurgery

  • Infection was treated with antibiotics and saline rinses

  • CRS symptoms continued

  • Endoscopy reveals thick mucus and residual scar tissue

  • Next steps: revision maxillary mega-antrostomy with PROPEL Contour

CRS, chronic rhinosinusitis.

*This case is intended for general medical education purposes only and is not a substitute for independent clinical medical judgment. Response to treatment may vary from patient to patient.

WATCH MORE MAXILLARY CASE STUDIES

PROPEL Contour is an hourglass-shaped implant, 8 mm in nominal length, and indicated for the frontal and or maxillary sinus ostia1

Surgery + PROPEL Contour provides benefits following maxillary sinus surgery1,2

  • PROPEL Contour delivery success rate (primary endpoint) in maxillary sinuses was 95.2% (N=15)

  • 100% maxillary sinus ostial patency (secondary endpoint) was achieved at Day 30 (N=15)

  • Reduction in inflammation was observed at Day 30

Study Design: EXCEED was a 15-patient, prospective, single-arm, open-label feasibility trial. Patients were implanted with PROPEL Contour into the maxillary sinus ostia following sinus surgery with traditional instrumentation, balloon dilation, or a hybrid of both.1,3

For significant improvements to patient outcomes following sinus surgery, add PROPEL Contour to your battle for the maxillary sinus*

PRE-OP

Post-ess

4 months post-ess

ESS, endoscopic sinus surgery.

*Representative outcome of a single patient. Individual results may vary.

maxillary case studies

Optimal treatment following maxillary sinus surgery with a full arsenal of options including PROPEL Contour can help improve patient outcomes

GET PROPEL

Stay Informed

This site is intended for healthcare professionals in the United States

Instructions for Use:

PROPEL PROPEL MINI PROPEL MINI WITH SDS PROPEL CONTOUR
Stay Informed

References

  1. PROPEL Contour [Instructions for Use]. Menlo Park, CA: Intersect ENT; 2016.
  2. Data on file, Intersect ENT, Inc. EXCEED Clinical Study Report. Study #P500-0414, Doc #R 28019 Rev 1.0, March 28, 2016.
  3. ClinicalTrials.gov. Clinical Evaluation of Propel Nova Sinus Implant in Peripheral Sinus Ostia (EXCEED). https://clinicaltrials.gov/ct2/show/NCT02228720?term=exceed+propel&rank=1. Accessed June 20, 2019.

The PROPEL sinus implants are intended to maintain patency and locally deliver steroid to the sinus mucosa in patients ≥18 years of age following sinus surgery: PROPEL for the ethmoid sinus, PROPEL Mini for the ethmoid sinus/frontal sinus opening, and PROPEL Contour for the frontal/maxillary sinus ostia. Contraindications include patients with confirmed hypersensitivity or intolerance to mometasone furoate (MF) or hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implant in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, displacement of the implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection. For full prescribing information see IFU at www.IntersectENT.com/technologies/. Rx only.

© 2024 Intersect ENT, Inc. All rights reserved. Intersect ENT and PROPEL are registered trademarks of Intersect ENT, Inc. in the United States and other countries. MPM-11549 Rev 7.0

The above-identified implants, delivery systems, and/or the use of the above-identified implants/delivery systems in a method may be covered by one or more U.S. and/foreign patents, found at intersectent.com/patents.